Zenith Healthcare has informed that the Provisions contained in SEBI Circular number SEBI/HO/DDHS/CIR/P/144 dated 26th November 2018 regarding raising of funds through issue of Debt Securities by Large Corporate Entities, is not applicable to the company as it does not fall under the category of ‘Large Corporate’ as specified in above circular for the financial year ended as on 31st March 2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1819.95 |
| Dr. Reddys Lab | 1278.10 |
| Cipla | 1328.95 |
| Zydus Lifesciences | 907.15 |
| Lupin | 2333.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: